Temporal trends and regional disparities in cancer screening utilization: an observational Swiss claims-based study.

Adjusted testing utilization varied little between 2014 and 2018; there was an increasing trend of 0.8% (0.6–1.0%) for colonoscopy/FOBT and of 0.5% (0.2–0.8%) for PSA testing, while mammography use decreased by 1.5% (1.2–1.7%).

also in 63,971 other papers

Annual participation rates for breast cancer screening varied between 23 and 84% in 17 European countries with mostly organized national or regional breast screening programs, with a decreasing trend even before 2014 [ 14 ].

also in 47,180 other papers